Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Palak H. Mehta"'
Autor:
Palak H. Mehta, Salvatore Fiorenza, Rachel M. Koldej, Anthony Jaworowski, David S. Ritchie, Kylie M. Quinn
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
A range of emerging therapeutic approaches for the treatment of cancer aim to induce or augment endogenous T cell responses. Chimeric antigen receptor (CAR) T cell therapy (CTT) is one such approach that utilises the patient’s own T cells, engineer
Externí odkaz:
https://doaj.org/article/aadff898576844feb5cfd0a605822392
Autor:
Kara J. Filbey, Palak H. Mehta, Kimberley J. Meijlink, Christophe Pellefigues, Alfonso J. Schmidt, Graham Le Gros
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Helminths regulate host immune responses to ensure their own long-term survival. Numerous studies have demonstrated that these helminth-induced regulatory mechanisms can also limit host inflammatory responses in several disease models. We used the He
Externí odkaz:
https://doaj.org/article/b65568ea2c09443eb87a1ac156163551
Autor:
Rachel Koldej, Anthony Jaworowski, David Ritchie, Salvatore Fiorenza, Kylie M. Quinn, Palak H. Mehta
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
A range of emerging therapeutic approaches for the treatment of cancer aim to induce or augment endogenous T cell responses. Chimeric antigen receptor (CAR) T cell therapy (CTT) is one such approach that utilises the patient’s own T cells, engineer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c096f3ec4614174a8196a348e5c14f
https://doi.org/10.3389/fimmu.2021.780442
https://doi.org/10.3389/fimmu.2021.780442